{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:49:19Z","timestamp":1761976159066,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clinre.2025.102668","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:18:50Z","timestamp":1755098330000},"page":"102668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Portal hypertension in alcohol-associated hepatitis: harmless and the reflection of systemic inflammation?"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9249-898X","authenticated-orcid":false,"given":"Karim","family":"Gebara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Moulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Pissarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges-Philippe","family":"Pageaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Ursic-Bedoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clinre.2025.102668_bib0001","doi-asserted-by":"crossref","first-page":"318\u201124","DOI":"10.1016\/j.jhep.2018.02.022","article-title":"The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis","volume":"69","author":"Serst\u00e9","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2025.102668_bib0002","doi-asserted-by":"crossref","DOI":"10.3350\/cmh.2024.0835","article-title":"Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000-2021","author":"Danpanichkul","year":"2025","journal-title":"Clin Mol Hepatol"},{"issue":"S1","key":"10.1016\/j.clinre.2025.102668_bib0003","doi-asserted-by":"crossref","first-page":"122\u20117","DOI":"10.1111\/liv.14366","article-title":"What\u2019s new in portal hypertension?","volume":"40","author":"Mauro","year":"2020","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.clinre.2025.102668_bib0004","doi-asserted-by":"crossref","first-page":"155\u201163","DOI":"10.1016\/j.jhep.2014.03.014","article-title":"Inflammation and portal hypertension - the undiscovered country","volume":"61","author":"Mehta","year":"2014","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.clinre.2025.102668_bib0005","doi-asserted-by":"crossref","first-page":"895\u2011910","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation","volume":"81","author":"Taru","year":"2024","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.clinre.2025.102668_bib0006","doi-asserted-by":"crossref","first-page":"337\u201143","DOI":"10.1007\/BF01296284","article-title":"Relationship between degree of portal hypertension and liver histologic lesions in patients with alcoholic cirrhosis. Effect of acute alcoholic hepatitis on portal hypertension","volume":"32","author":"Poynard","year":"1987","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.clinre.2025.102668_bib0007","doi-asserted-by":"crossref","first-page":"841\u20118","DOI":"10.1111\/j.1365-2036.2007.03258.x","article-title":"Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis","volume":"25","author":"Rincon","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.clinre.2025.102668_bib0008","doi-asserted-by":"crossref","first-page":"67\u201173","DOI":"10.1007\/s11901-023-00601-y","article-title":"Portal hypertension in alcohol-associated hepatitis","volume":"22","author":"McConnell","year":"2023","journal-title":"Curr Hepatol Rep"},{"issue":"5","key":"10.1016\/j.clinre.2025.102668_bib0009","doi-asserted-by":"crossref","first-page":"1572\u201185","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.clinre.2025.102668_bib0010","doi-asserted-by":"crossref","first-page":"1182\u20117","DOI":"10.1136\/gut.52.8.1182","article-title":"Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis","volume":"52","author":"Mookerjee","year":"2003","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.clinre.2025.102668_bib0011","doi-asserted-by":"crossref","first-page":"816\u201121","DOI":"10.1016\/j.jhep.2014.11.003","article-title":"Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleeding","volume":"62","author":"Rudler","year":"2015","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2025.102668_bib0012","first-page":"1348\u201154","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatol Balt Md"},{"issue":"3","key":"10.1016\/j.clinre.2025.102668_bib0013","doi-asserted-by":"crossref","first-page":"233\u201140","DOI":"10.1053\/jlts.2002.31654","article-title":"Body surface area and body weight predict total liver volume in western adults","volume":"8","author":"Vauthey","year":"2002","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.clinre.2025.102668_bib0014","doi-asserted-by":"crossref","first-page":"810\u20119","DOI":"10.1016\/j.jhep.2021.05.029","article-title":"Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease","volume":"75","author":"Lackner","year":"2021","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102668_bib0015","first-page":"217\u201131","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102668_bib0016","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231208","article-title":"CT rule-in and rule-out criteria for clinically significant portal hypertension in chronic liver disease","volume":"309","author":"Heo","year":"2023","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.clinre.2025.102668_bib0017","first-page":"431\u201149","article-title":"Variable selection - a review and recommendations for the practicing statistician","volume":"60","author":"Heinze","year":"2018","journal-title":"Biom J Biom Z"},{"issue":"4","key":"10.1016\/j.clinre.2025.102668_bib0018","first-page":"555\u201164","article-title":"Alcoholic hepatitis: current challenges and future directions","volume":"12","author":"Singal","year":"2014","journal-title":"Clin Gastroenterol Hepatol Clin Pr J Am Gastroenterol Assoc"},{"issue":"2","key":"10.1016\/j.clinre.2025.102668_bib0019","doi-asserted-by":"crossref","first-page":"541\u20118","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.clinre.2025.102668_bib0020","doi-asserted-by":"crossref","first-page":"967\u201174","DOI":"10.1097\/MEG.0000000000001148","article-title":"A return to harmful alcohol consumption impacts on portal hemodynamic changes following alcoholic hepatitis","volume":"30","author":"Spahr","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102668_bib0021","doi-asserted-by":"crossref","first-page":"298\u2011307","DOI":"10.1007\/s10620-023-08144-4","article-title":"Severity of acute portal hypertension determines the clinical outcomes in severe alcoholic hepatitis","volume":"69","author":"Jindal","year":"2024","journal-title":"Dig Dis Sci"},{"issue":"10","key":"10.1016\/j.clinre.2025.102668_bib0022","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201901327R","article-title":"Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis","volume":"33","author":"Juanola","year":"2019","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.clinre.2025.102668_bib0023","doi-asserted-by":"crossref","first-page":"421\u20117","DOI":"10.1007\/s11684-012-0223-5","article-title":"Assessment of liver volume variation to evaluate liver function","volume":"6","author":"Tong","year":"2012","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.clinre.2025.102668_bib0024","doi-asserted-by":"crossref","first-page":"786\u201196","DOI":"10.1016\/S0016-5085(82)80007-3","article-title":"Occlusive venous lesions in alcoholic liver disease. A study of 200 cases","volume":"83","author":"Goodman","year":"1982","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.clinre.2025.102668_bib0025","first-page":"1390\u20117","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatol Balt Md"},{"issue":"11","key":"10.1016\/j.clinre.2025.102668_bib0026","doi-asserted-by":"crossref","first-page":"2747\u201156","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A new scoring system for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.clinre.2025.102668_bib0027","doi-asserted-by":"crossref","first-page":"1953\u201160","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinre.2025.102668_bib0028","article-title":"Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension","volume":"10","author":"Chen","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.clinre.2025.102668_bib0029","first-page":"17\u201121","article-title":"Neutrophilic infiltration in alcoholic hepatitis","volume":"27","author":"Bautista","year":"2002","journal-title":"Alcohol Fayettev N"},{"issue":"1","key":"10.1016\/j.clinre.2025.102668_bib0030","first-page":"29\u201136","article-title":"Lymphocyte recruitment to the liver in alcoholic liver disease","volume":"27","author":"Haydon","year":"2002","journal-title":"Alcohol Fayettev N"},{"issue":"11","key":"10.1016\/j.clinre.2025.102668_bib0031","doi-asserted-by":"crossref","first-page":"1749\u201156","DOI":"10.1038\/ajg.2014.262","article-title":"Hepatic macrophage activation and the LPS pathway in patients with alcoholic hepatitis: a prospective cohort study","volume":"109","author":"Sandahl","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.clinre.2025.102668_bib0032","doi-asserted-by":"crossref","first-page":"1211\u201120","DOI":"10.1111\/j.1582-4934.2009.00811.x","article-title":"Leukocyte-endothelial interactions in inflammation","volume":"13","author":"Langer","year":"2009","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.clinre.2025.102668_bib0033","doi-asserted-by":"crossref","first-page":"168\u201179","DOI":"10.1136\/gutjnl-2021-326076","article-title":"Interleukin-11 drives human and mouse alcohol-related liver disease","volume":"72","author":"Effenberger","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2025.102668_bib0034","article-title":"Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure","author":"Murakami","year":"2023","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.clinre.2025.102668_bib0035","doi-asserted-by":"crossref","first-page":"441\u201153","DOI":"10.1002\/hep.31046","article-title":"An open-label, dose-escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcohol-associated hepatitis","volume":"72","author":"Arab","year":"2020","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2025.102668_bib0036","doi-asserted-by":"crossref","first-page":"1564\u201177","DOI":"10.1053\/j.gastro.2018.07.022","article-title":"Simvastatin prevents progression of acute on chronic liver failure in rats with cirrhosis and portal hypertension","volume":"155","author":"Tripathi","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.clinre.2025.102668_bib0037","first-page":"1464\u201173","article-title":"Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: a prospective study","volume":"66","author":"Louvet","year":"2017","journal-title":"Hepatol Balt Md"},{"issue":"4","key":"10.1016\/j.clinre.2025.102668_bib0038","doi-asserted-by":"crossref","first-page":"1253\u201162","DOI":"10.1097\/HEP.0000000000000267","article-title":"Multicentered study of patient outcomes after declined for early liver transplantation in severe alcohol-associated hepatitis","volume":"77","author":"Hsu","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2025.102668_bib0039","doi-asserted-by":"crossref","first-page":"225\u201142","DOI":"10.1097\/HEP.0000000000000298","article-title":"Alcohol-induced extracellular ASC specks perpetuate liver inflammation and damage in alcohol-associated hepatitis even after alcohol cessation","volume":"78","author":"De Carvalho Ribeiro","year":"2023","journal-title":"Hepatology"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125001457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125001457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:34:45Z","timestamp":1759548885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740125001457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2210740125001457"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102668","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Portal hypertension in alcohol-associated hepatitis: harmless and the reflection of systemic inflammation?","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102668"}}